Lexaria and Neutrisci form JV to commercialize line of edible cannabinoid products

|About: Lexaria Bioscience Corp. (LXRP)|By:, SA News Editor

Lexaria Bioscience (OTCQB:LXRP) and Neutrisci International (OTCQB:NRXCF) ink a joint venture to produce and commercialize a line of healthy, sugar-free, edible cannabinoid mouth-melt products based on Lexaria's lipid-delivery technology and Neutrisci's pterostilbene tablet form factor. The JV will operate under the name Ambarii Trade Corporation with profits to be equally shared.

Ambarii plans to secure licenses in California, Colorado and Canada to manufacture and sell mouth-melt products containing THC.